Literature DB >> 29323819

The Use of a Statewide Prescription Drug Monitoring Program by Emergency Department Physicians.

Jennifer L Hernandez-Meier1,2, Rachel Muscott3, Amy Zosel2.   

Abstract

BACKGROUND: Little is known about how emergency physicians have used Wisconsin's Prescription Drug Monitoring Program (PDMP).
OBJECTIVE: To characterize emergency physician knowledge and utilization of the program and how it modifies practice.
METHODS: Online survey data were collected 1 year after program implementation. Descriptive statistics were generated and qualitative responses were grouped by content.
RESULTS: Of the 63 respondents, 64.1% had used the program. Lack of a DEA number and knowledge about how to sign up were the most common barriers to registration. Over 97% of program users found it useful for confirming suspicion of drug abuse and 90% wrote fewer prescriptions after program implementation. Time constraints and the difficult log-in process were common barriers to use. More users than nonusers stated that their workplace was supportive of program use.
CONCLUSIONS: Although barriers exist, PDMP utilization appears useful to emergency physicians and associated with modifications to patient management.

Entities:  

Mesh:

Year:  2017        PMID: 29323819

Source DB:  PubMed          Journal:  WMJ        ISSN: 1098-1861


  4 in total

1.  Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study.

Authors:  Patricia R Freeman; Geoffrey M Curran; Karen L Drummond; Bradley C Martin; Benjamin S Teeter; Katharine Bradley; Nancy Schoenberg; Mark J Edlund
Journal:  Res Social Adm Pharm       Date:  2018-09-14

2.  Impact of a Mandatory Prescription Drug Monitoring Program Check on Emergency Department Opioid Prescribing Rates.

Authors:  C James Watson; Michael Ganetsky; Ryan C Burke; Yotam Dizitzer; Evan L Leventhal; Katherine L Boyle
Journal:  J Med Toxicol       Date:  2021-04-05

3.  Effects of Implementation and Enforcement Differences in Prescription Drug Monitoring Programs in 3 States: Connecticut, Kentucky, and Wisconsin.

Authors:  Julia Dickson-Gomez; Erika Christenson; Margaret Weeks; Carol Galletly; Jennifer Wogen; Antoinette Spector; Madelyn McDonald; Jessica Ohlrich
Journal:  Subst Abuse       Date:  2021-03-25

4.  Health Care Provider Utilization of Prescription Monitoring Programs: A Systematic Review and Meta-Analysis.

Authors:  Alysia Robinson; Maria N Wilson; Jill A Hayden; Emily Rhodes; Samuel Campbell; Peter MacDougall; Mark Asbridge
Journal:  Pain Med       Date:  2021-07-25       Impact factor: 3.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.